Spire Healthcare Group (LON:SPI – Get Free Report) announced its quarterly earnings data on Thursday. The company reported GBX 8.80 ($0.11) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%.
Spire Healthcare Group Stock Performance
LON:SPI opened at GBX 181.01 ($2.33) on Friday. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The stock has a 50 day simple moving average of GBX 228.24 and a 200 day simple moving average of GBX 230.26. Spire Healthcare Group has a 1-year low of GBX 168.20 ($2.17) and a 1-year high of GBX 270.50 ($3.49). The stock has a market cap of £726.88 million, a P/E ratio of 25.76, a PEG ratio of 1.06 and a beta of 0.96.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft cut their target price on shares of Spire Healthcare Group from GBX 320 ($4.12) to GBX 300 ($3.87) and set a “buy” rating for the company in a research note on Thursday.
Spire Healthcare Group Company Profile
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
See Also
- Five stocks we like better than Spire Healthcare Group
- 3 Warren Buffett Stocks to Buy Now
- 4 EV Stocks Facing Uncertainty—Which Ones Will Survive?
- How to Invest in the FAANG Stocks
- These 3 Big Banks Are Set to Gain as Consumers Stash More Cash
- 3 Healthcare Dividend Stocks to Buy
- Wall Street Says Chipotle Has 30% Upside—Should You Bite?
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.